JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD.

Andere talen Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Aandelen

600513

CNE000001DP6

slotkoers Shanghai S.E. Andere beurzen 00:00:00 14-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
8,27 ^CNY	-0,12%		-0,12%	-25,76%

05/06	China keurt prostaatkankertabletten van Lianhuan Pharma goed	MT
29/04	Jiangsu Lianhuan Pharmaceutical Co, Ltd. Rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

China Approves Lianhuan Pharma's Prostate Cancer Tablets	05/06
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Lianhuan Pharma Obtains China Registration Approval for Antihistamine	09/04
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
Lianhuan Pharma's Production Lines Pass GMP Inspection	07/11
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30-10-23
Jiangsu Lianhuan Pharma Passes GMP Compliance Inspection	19-10-23
MFM KOREA Co., Ltd. announced that it expects to receive KRW 23.99999924 billion in funding from Jiangsu Lianhuan Pharmaceutical Co., Ltd. and other investors	06-10-23
Jiangsu Lianhuan Pharma Gets Nod to Market Ingredient For Drug Against Addison’s Disease	15-09-23
Jiangsu Lianhuan Pharma Plans Listing Unit on ‘New Third Board’	12-09-23
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25-08-23
Foyou Pharma Passes Drug GMP Compliance Inspection	14-06-23
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28-04-23
Jiangsu Lianhuan Pharma to Raise 450 Million Yuan From Bond Sale	09-03-23
Lianhuan Pharma Gets Nod for Erectile Dysfunction Drug	06-03-23
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	02-03-23
Jiangsu Lianhuan Pharmaceutical Gets Nod to Market Antihistamine Ingredient in China	10-02-23
Lianhuan Pharma Gets Nod for Anti-Allergy Drug Registration	09-01-23
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	21-10-22
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	24-08-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Aandelen

600513

CNE000001DP6

Andere talen

Filters